Selected article for: "human cell and non targeting control comparison"

Author: Yang, Darong; Li, Nan L.; Wei, Dahai; Liu, Baoming; Guo, Fang; Elbahesh, Husni; Zhang, Yunzhi; Zhou, Zhi; Chen, Guo-Yun; Li, Kui
Title: The E3 ligase TRIM56 is a host restriction factor of Zika virus and depends on its RNA-binding activity but not miRNA regulation, for antiviral function
  • Document date: 2019_6_28
  • ID: 1nr0hggt_16
    Snippet: HeLa cells with stable, shRNA-mediated knockdown of TRIM56 (HeLa-shT56) and control cells stably transduced with a non-targeting shRNA (HeLa-shCtrl) were described in a previous study [24] . To deplete TRIM56 expression in SVGA cells, we transduced the cells with lentiviral shRNA-094 specifically targeting human TRIM56 [24] and selected cell populations resistant to puromycin. For comparison, control cells were generated by transduction with a no.....
    Document: HeLa cells with stable, shRNA-mediated knockdown of TRIM56 (HeLa-shT56) and control cells stably transduced with a non-targeting shRNA (HeLa-shCtrl) were described in a previous study [24] . To deplete TRIM56 expression in SVGA cells, we transduced the cells with lentiviral shRNA-094 specifically targeting human TRIM56 [24] and selected cell populations resistant to puromycin. For comparison, control cells were generated by transduction with a non-targeting control lentiviral shRNA packaged from pLKO.1-shRNA-scramble (Addgene# 1864), followed by selection in puromycin-containing medium. For transient knockdown of TLR3, a synthetic siRNA specifically targeting human TLR3 (siTLR3) [40] was transfected into cells by Lipofectamine 2000 for the indicated times as per manufacturer's instructions (Invitrogen). As a control for comparison, a non-targeting negative control siRNA (Invitrogen AM4636) was used in lieu of siTLR3.

    Search related documents:
    Co phrase search for related documents
    • cell population and HeLa cell: 1
    • cell population and human target: 1, 2, 3, 4
    • cell population and negative control: 1
    • cell population and previous study: 1, 2, 3
    • comparison control and control cell: 1, 2, 3, 4
    • comparison control and human target: 1
    • comparison control and negative control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • comparison control and non targeting control: 1
    • comparison control and previous study: 1, 2, 3, 4
    • control cell and HeLa cell: 1, 2, 3
    • control cell and human target: 1, 2
    • control cell and Invitrogen instruction: 1
    • control cell and negative control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • control cell and previous study: 1, 2, 3
    • HeLa cell and human target: 1
    • HeLa cell and Invitrogen instruction: 1
    • HeLa cell and negative control: 1, 2
    • human target and negative control: 1, 2, 3
    • human target and previous study: 1